Citius Pharmaceuticals
CTXR • NASDAQ
Citius Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Leonard L. Mazur, with a market cap of $18.9M.
Market Cap$18.9M
Employees22.0
CEOLeonard L. Mazur
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ2 2026
Financials
Citius Pharmaceuticals FAQ
Common questions about Citius Pharmaceuticals
Citius Pharmaceuticals is scheduled to report earnings for Q2 2026 on May 13, 2026. Analysts estimate revenue of $9.9M.
Citius Pharmaceuticals has approximately 22 employees.